Unknown

Dataset Information

0

Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPAR? ligands.


ABSTRACT: Peroxisome proliferator-activated receptor gamma (PPAR?) is a ligand-regulated transcription factor that plays crucial roles in adipogenesis, lipid metabolism, and glucose homeostasis. Several PPAR? ligands possess anti-diabetic activity and they commonly inhibit the phosphorylation of PPAR? at serine 273 (Ser273). The recently reported PPAR? ligand SR1664, which selectively blocks the phosphorylation of PPAR? without classical agonism, has potent anti-diabetic activity, indicating that the inhibition of Ser273 phosphorylation is sufficient to provoke anti-diabetic effects. In this study, we revealed the X-ray structure of PPAR? co-crystallized with SR1664 bound to the alternate binding site of PPAR? and confirmed that the alternate site binding of SR1664 blocks the phosphorylation of Ser273. Furthermore, using covalent inhibitors as chemical tools, we demonstrated that the inhibition of phosphorylation is attributed to the occupation of a specific site which is a hydrophobic region between helix 3 and ?3-?4 at the binding pocket of PPAR?. In high-fat diet-induced obese mice, we confirmed the anti-diabetic activity of our covalent inhibitor SB1453 that was designed to bind at the specific site in PPAR? for blocking the phosphorylation of Ser273. Lastly, the target selectivity of SB1453 was demonstrated by fluorescence-based visualization of target proteins complexed with the covalent probe 11 containing a bioorthogonal functional group.

SUBMITTER: Bae H 

PROVIDER: S-EPMC6021786 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands.

Bae Hwan H   Jang Jun Young JY   Choi Sun-Sil SS   Lee Jae-Jin JJ   Kim Heejun H   Jo Ala A   Lee Kong-Joo KJ   Choi Jang Hyun JH   Suh Se Won SW   Park Seung Bum SB  

Chemical science 20160513 8


Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-regulated transcription factor that plays crucial roles in adipogenesis, lipid metabolism, and glucose homeostasis. Several PPARγ ligands possess anti-diabetic activity and they commonly inhibit the phosphorylation of PPARγ at serine 273 (Ser273). The recently reported PPARγ ligand SR1664, which selectively blocks the phosphorylation of PPARγ without classical agonism, has potent anti-diabetic activity, indicating that the inhi  ...[more]

Similar Datasets

| S-EPMC5484537 | biostudies-literature
2023-11-29 | PXD045712 | Pride
2023-11-29 | PXD045715 | Pride
| S-EPMC9611956 | biostudies-literature
| S-EPMC2920453 | biostudies-literature
2018-12-10 | GSE118589 | GEO
| S-EPMC10462138 | biostudies-literature
| S-EPMC7582602 | biostudies-literature
| S-EPMC4963535 | biostudies-literature
| S-EPMC5758645 | biostudies-literature